To develop a novel revaprazan-loaded gelatin microsphere with enhanced solubility and oral bioavailability, numerous gelatin microspheres were prepared using a spray-drying technique. The impact of gelatin amount on drug solubility in the gelatin microspheres was investigated. The physicochemical properties of the selected gelatin microsphere, such as shape, particle size and crystallinity, were evaluated. Moreover, its dissolution and pharmacokinetics in rats were assessed in comparison with revaprazan powder. Amongst the gelatin microspheres tested, the gelatin microsphere consisting of revaprazan and gelatin (1:2, w/w), which gave about 150-fold increased solubility, had the most enhanced drug solubility. It provided a spherical shape, amorphous drug and reduced particle size. Furthermore, it gave a higher dissolution rate and plasma concentration than did revaprazan powder. Particularly, it gave about 2.3-fold improved oral bioavailability in comparison with revaprazan powder. Therefore, this novel gelatin microsphere system is recommended as an oral pharmaceutical product of poorly water-soluble revaprazan.